AAPT Diagnostic Criteria for Fibromyalgia

Lesley M. Arnold, Robert (Rob) Bennett, Leslie J. Crofford, Linda E. Dean, Daniel J. Clauw, Don L. Goldenberg, Mary Ann Fitzcharles, Eduardo S. Paiva, Roland Staud, Piercarlo Sarzi-Puttini, Dan Buskila, Gary J. Macfarlane

    Research output: Contribution to journalArticle

    3 Citations (Scopus)

    Abstract

    Fibromyalgia (FM) is a common chronic pain disorder that presents diagnostic challenges for clinicians. Several classification, diagnostic and screening criteria have been developed over the years, but there continues to be a need to develop criteria that reflect the current understanding of FM and are practical for use by clinicians and researchers. The Analgesic, Anesthetic, and Addiction Clinical Trial Translations Innovations Opportunities and Networks (ACTTION) public-private partnership with the U.S. Food and Drug Administration (FDA) and the American Pain Society (APS) initiated the ACTTION-APS Pain Taxonomy (AAPT) to develop a diagnostic system that would be clinically useful and consistent across chronic pain disorders. The AAPT established an international FM working group consisting of clinicians and researchers with expertise in FM to generate core diagnostic criteria for FM and apply the multidimensional diagnostic framework adopted by AAPT to FM. The process for developing the AAPT criteria and dimensions included literature reviews and synthesis, consensus discussions, and analyses of data from large population-based studies conducted in the United Kingdom. The FM working group established a revised diagnosis of FM and identified risk factors, course, prognosis, and pathophysiology of FM. Future studies will assess the criteria for feasibility, reliability, and validity. Revisions of the dimensions will also be required as research advances our understanding of FM. Perspective: The ACTTION-APS FM taxonomy provides an evidence-based diagnostic system for FM. The taxonomy includes diagnostic criteria, common features, comorbidities, consequences, and putative mechanisms. This approach might improve the recognition of FM in clinical practice.

    Original languageEnglish (US)
    JournalJournal of Pain
    DOIs
    StateAccepted/In press - Jan 1 2018

    Fingerprint

    Fibromyalgia
    Pain
    Somatoform Disorders
    Clinical Trials
    Chronic Pain
    Research Personnel
    Public-Private Sector Partnerships
    United States Food and Drug Administration
    Reproducibility of Results
    Analgesics
    Anesthetics
    Comorbidity
    Consensus

    Keywords

    • AAPT
    • criteria
    • diagnosis
    • dimensions
    • Fibromyalgia

    ASJC Scopus subject areas

    • Neurology
    • Clinical Neurology
    • Anesthesiology and Pain Medicine

    Cite this

    Arnold, L. M., Bennett, R. R., Crofford, L. J., Dean, L. E., Clauw, D. J., Goldenberg, D. L., ... Macfarlane, G. J. (Accepted/In press). AAPT Diagnostic Criteria for Fibromyalgia. Journal of Pain. https://doi.org/10.1016/j.jpain.2018.10.008

    AAPT Diagnostic Criteria for Fibromyalgia. / Arnold, Lesley M.; Bennett, Robert (Rob); Crofford, Leslie J.; Dean, Linda E.; Clauw, Daniel J.; Goldenberg, Don L.; Fitzcharles, Mary Ann; Paiva, Eduardo S.; Staud, Roland; Sarzi-Puttini, Piercarlo; Buskila, Dan; Macfarlane, Gary J.

    In: Journal of Pain, 01.01.2018.

    Research output: Contribution to journalArticle

    Arnold, LM, Bennett, RR, Crofford, LJ, Dean, LE, Clauw, DJ, Goldenberg, DL, Fitzcharles, MA, Paiva, ES, Staud, R, Sarzi-Puttini, P, Buskila, D & Macfarlane, GJ 2018, 'AAPT Diagnostic Criteria for Fibromyalgia', Journal of Pain. https://doi.org/10.1016/j.jpain.2018.10.008
    Arnold LM, Bennett RR, Crofford LJ, Dean LE, Clauw DJ, Goldenberg DL et al. AAPT Diagnostic Criteria for Fibromyalgia. Journal of Pain. 2018 Jan 1. https://doi.org/10.1016/j.jpain.2018.10.008
    Arnold, Lesley M. ; Bennett, Robert (Rob) ; Crofford, Leslie J. ; Dean, Linda E. ; Clauw, Daniel J. ; Goldenberg, Don L. ; Fitzcharles, Mary Ann ; Paiva, Eduardo S. ; Staud, Roland ; Sarzi-Puttini, Piercarlo ; Buskila, Dan ; Macfarlane, Gary J. / AAPT Diagnostic Criteria for Fibromyalgia. In: Journal of Pain. 2018.
    @article{1fb1bd57ca0848b78a3c6bdaca81c375,
    title = "AAPT Diagnostic Criteria for Fibromyalgia",
    abstract = "Fibromyalgia (FM) is a common chronic pain disorder that presents diagnostic challenges for clinicians. Several classification, diagnostic and screening criteria have been developed over the years, but there continues to be a need to develop criteria that reflect the current understanding of FM and are practical for use by clinicians and researchers. The Analgesic, Anesthetic, and Addiction Clinical Trial Translations Innovations Opportunities and Networks (ACTTION) public-private partnership with the U.S. Food and Drug Administration (FDA) and the American Pain Society (APS) initiated the ACTTION-APS Pain Taxonomy (AAPT) to develop a diagnostic system that would be clinically useful and consistent across chronic pain disorders. The AAPT established an international FM working group consisting of clinicians and researchers with expertise in FM to generate core diagnostic criteria for FM and apply the multidimensional diagnostic framework adopted by AAPT to FM. The process for developing the AAPT criteria and dimensions included literature reviews and synthesis, consensus discussions, and analyses of data from large population-based studies conducted in the United Kingdom. The FM working group established a revised diagnosis of FM and identified risk factors, course, prognosis, and pathophysiology of FM. Future studies will assess the criteria for feasibility, reliability, and validity. Revisions of the dimensions will also be required as research advances our understanding of FM. Perspective: The ACTTION-APS FM taxonomy provides an evidence-based diagnostic system for FM. The taxonomy includes diagnostic criteria, common features, comorbidities, consequences, and putative mechanisms. This approach might improve the recognition of FM in clinical practice.",
    keywords = "AAPT, criteria, diagnosis, dimensions, Fibromyalgia",
    author = "Arnold, {Lesley M.} and Bennett, {Robert (Rob)} and Crofford, {Leslie J.} and Dean, {Linda E.} and Clauw, {Daniel J.} and Goldenberg, {Don L.} and Fitzcharles, {Mary Ann} and Paiva, {Eduardo S.} and Roland Staud and Piercarlo Sarzi-Puttini and Dan Buskila and Macfarlane, {Gary J.}",
    year = "2018",
    month = "1",
    day = "1",
    doi = "10.1016/j.jpain.2018.10.008",
    language = "English (US)",
    journal = "Journal of Pain",
    issn = "1526-5900",
    publisher = "Churchill Livingstone",

    }

    TY - JOUR

    T1 - AAPT Diagnostic Criteria for Fibromyalgia

    AU - Arnold, Lesley M.

    AU - Bennett, Robert (Rob)

    AU - Crofford, Leslie J.

    AU - Dean, Linda E.

    AU - Clauw, Daniel J.

    AU - Goldenberg, Don L.

    AU - Fitzcharles, Mary Ann

    AU - Paiva, Eduardo S.

    AU - Staud, Roland

    AU - Sarzi-Puttini, Piercarlo

    AU - Buskila, Dan

    AU - Macfarlane, Gary J.

    PY - 2018/1/1

    Y1 - 2018/1/1

    N2 - Fibromyalgia (FM) is a common chronic pain disorder that presents diagnostic challenges for clinicians. Several classification, diagnostic and screening criteria have been developed over the years, but there continues to be a need to develop criteria that reflect the current understanding of FM and are practical for use by clinicians and researchers. The Analgesic, Anesthetic, and Addiction Clinical Trial Translations Innovations Opportunities and Networks (ACTTION) public-private partnership with the U.S. Food and Drug Administration (FDA) and the American Pain Society (APS) initiated the ACTTION-APS Pain Taxonomy (AAPT) to develop a diagnostic system that would be clinically useful and consistent across chronic pain disorders. The AAPT established an international FM working group consisting of clinicians and researchers with expertise in FM to generate core diagnostic criteria for FM and apply the multidimensional diagnostic framework adopted by AAPT to FM. The process for developing the AAPT criteria and dimensions included literature reviews and synthesis, consensus discussions, and analyses of data from large population-based studies conducted in the United Kingdom. The FM working group established a revised diagnosis of FM and identified risk factors, course, prognosis, and pathophysiology of FM. Future studies will assess the criteria for feasibility, reliability, and validity. Revisions of the dimensions will also be required as research advances our understanding of FM. Perspective: The ACTTION-APS FM taxonomy provides an evidence-based diagnostic system for FM. The taxonomy includes diagnostic criteria, common features, comorbidities, consequences, and putative mechanisms. This approach might improve the recognition of FM in clinical practice.

    AB - Fibromyalgia (FM) is a common chronic pain disorder that presents diagnostic challenges for clinicians. Several classification, diagnostic and screening criteria have been developed over the years, but there continues to be a need to develop criteria that reflect the current understanding of FM and are practical for use by clinicians and researchers. The Analgesic, Anesthetic, and Addiction Clinical Trial Translations Innovations Opportunities and Networks (ACTTION) public-private partnership with the U.S. Food and Drug Administration (FDA) and the American Pain Society (APS) initiated the ACTTION-APS Pain Taxonomy (AAPT) to develop a diagnostic system that would be clinically useful and consistent across chronic pain disorders. The AAPT established an international FM working group consisting of clinicians and researchers with expertise in FM to generate core diagnostic criteria for FM and apply the multidimensional diagnostic framework adopted by AAPT to FM. The process for developing the AAPT criteria and dimensions included literature reviews and synthesis, consensus discussions, and analyses of data from large population-based studies conducted in the United Kingdom. The FM working group established a revised diagnosis of FM and identified risk factors, course, prognosis, and pathophysiology of FM. Future studies will assess the criteria for feasibility, reliability, and validity. Revisions of the dimensions will also be required as research advances our understanding of FM. Perspective: The ACTTION-APS FM taxonomy provides an evidence-based diagnostic system for FM. The taxonomy includes diagnostic criteria, common features, comorbidities, consequences, and putative mechanisms. This approach might improve the recognition of FM in clinical practice.

    KW - AAPT

    KW - criteria

    KW - diagnosis

    KW - dimensions

    KW - Fibromyalgia

    UR - http://www.scopus.com/inward/record.url?scp=85058705131&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85058705131&partnerID=8YFLogxK

    U2 - 10.1016/j.jpain.2018.10.008

    DO - 10.1016/j.jpain.2018.10.008

    M3 - Article

    JO - Journal of Pain

    JF - Journal of Pain

    SN - 1526-5900

    ER -